These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1196130)

  • 1. Effects of mazindol on carbohydrate and insulin metabolism in obesity.
    Harrison LC; King-Roach AP; Sandy KC
    Metabolism; 1975 Dec; 24(12):1353-65. PubMed ID: 1196130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine studies with mazindol in obese patients.
    Dolecek R
    Pharmatherapeutica; 1980; 2(5):309-16. PubMed ID: 6776543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of mazindol on insulin and glucagon secretion in ventromedial hypothalamic obese rats].
    Usami M; Seino Y; Nishi S; Nakahara H; Ikeda M; Matsukura S; Imura H
    Nihon Yakurigaku Zasshi; 1985 Apr; 85(4):297-303. PubMed ID: 3891549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double blind clinical trial of mazindol on weight loss blood glucose, plasma insulin and serum lipids in overweight diabetic patients.
    Slama G; Selmi A; Hautecouverture M; Tchobroutsky G
    Diabete Metab; 1978 Sep; 4(3):193-9. PubMed ID: 361463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of mazindol on metabolic and regulatory changes in obese women during weight reduction.
    Rath R; Vondra K; Bass A; Kujalova V; Wenkeova J
    Int J Obes; 1979; 3(2):133-40. PubMed ID: 93588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of mazindol on obesity induced by administration of gold thioglucose].
    Ohminami K; Matsuoka E; Takahashi Y; Shimizu D; Okuda H
    Nihon Yakurigaku Zasshi; 1984 Feb; 83(2):123-32. PubMed ID: 6430760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of mazindol and 46-034 (Sandoz) on glucose oxidation and insulin binding by rat isolated fat cells.
    Harrison LC; King-Roach AP
    Clin Exp Pharmacol Physiol; 1976; 3(5):503-6. PubMed ID: 975636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of action of mazindol in preventing onset and development of obesity induced by gold thioglucose injection.
    Kawano-Takahashi Y; Ohminaji H; Ubagai E; Okuda H
    Int J Obes; 1984; 8(6):655-64. PubMed ID: 6442712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of mazindol on body weight and insulin sensitivity in severely obese patients after a very-low-calorie diet therapy.
    Nishikawa T; Iizuka T; Omura M; Kuramoto N; Miki T; Ito H; Chiba S
    Endocr J; 1996 Dec; 43(6):671-7. PubMed ID: 9075607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciclazindol and mazindol on glucose uptake into human isolated skeletal muscle: no interaction of mazindol with methysergide.
    Kirby MJ; Turner P
    Br J Clin Pharmacol; 1977 Aug; 4(4):459-61. PubMed ID: 901738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term and long-term clinical evaluation of a non-amphetaminic anorexiant (mazindol) in the treatment of obesity.
    Enzi G; Baritussio A; Marchiori E; Crepaldi G
    J Int Med Res; 1976; 4(5):305-18. PubMed ID: 1028632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of mazindol on glucose absorption in everted rat small intestine].
    Tsuchiya M; Inoue S; Satta M; Yoshimura H; Arita M; Takamura Y
    Nihon Yakurigaku Zasshi; 1986 Jun; 87(6):649-54. PubMed ID: 3744170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of an anorexiant, mazindol, on metabolic abnormalities of rats with ventromedial hypothalamic lesions].
    Inoue S; Egawa M; Satoh S
    Nihon Yakurigaku Zasshi; 1984 May; 83(5):441-9. PubMed ID: 6469133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of mazindol on free fatty acid metabolism in the brain of rats].
    Mizobuchi M; Matsuoka N; Saito Y; Yoshida S; Kumagai A
    Nihon Yakurigaku Zasshi; 1984 Jan; 83(1):33-7. PubMed ID: 6714850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of mazindol on glucose uptake into human isolated skeletal muscle.
    Kirby MJ; Turner P
    J Pharm Pharmacol; 1976 Feb; 28(2):163-4. PubMed ID: 6681
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in meal pattern and endogenous feeding related substances following mazindol administration.
    Sakata T; Fujimoto K; Terada K; Arase K; Fukushima M
    Arch Int Pharmacodyn Ther; 1984 Jul; 270(1):11-28. PubMed ID: 6388520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and basic aspects of an anorexiant, mazindol, as an antiobesity agent in Japan.
    Inoue S; Egawa M; Satoh S; Saito M; Suzuki H; Kumahara Y; Abe M; Kumagai A; Goto Y; Shizume K
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):199S-202S. PubMed ID: 1728834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of mazindol on local cerebral glucose utilization in rats.
    Kubota M; Namba H; Sunami K; Yamaura A; Makino H; Murano S; Nishikawa T; Oheda T; Saito Y; Yoshida S
    Neuropharmacology; 1987 Sep; 26(9):1403-8. PubMed ID: 3670561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical studies with mazindol.
    Inoue S
    Obes Res; 1995 Nov; 3 Suppl 4():549S-552S. PubMed ID: 8697057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of mazindol on some parameters of energy metabolism regulation in weight reduction of obese subjects (author's transl)].
    Rath R; Vondra K; Bass A; Kujalová V
    Bratisl Lek Listy; 1978 Feb; 69(2):170-9. PubMed ID: 343887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.